Urticaria Day: Raising Awareness of Symptoms and Treatment Patient groups call attention to skin condition commonly known as hives GlobeNewswire October 01, 2025 Washington, DC, Oct. 01, 2025 (GLOBE NEWSWIRE) — On this Urticaria Day (UDAY), the Asthma and Allergy Foundation of America (AAFA), We CU, and The Mast Cell Disease Society (TMS) aim to […]
Avalo Therapeutics Expands Leadership Team with Key Appointments in Business Development and Human Resources GlobeNewswire October 01, 2025 WAYNE, Pa., Oct. 01, 2025 (GLOBE NEWSWIRE) — Avalo Therapeutics, Inc. (Nasdaq: AVTX), a clinical stage biotechnology company fully dedicated to developing IL-1B-based treatments for immune-mediated inflammatory diseases, today announced the expansion of its leadership team with
Climb Bio Appoints Susan Altschuller, Ph.D., MBA as Chief Financial Officer GlobeNewswire October 01, 2025 WELLESLEY HILLS, Mass., Oct. 01, 2025 (GLOBE NEWSWIRE) — Climb Bio, Inc. (Nasdaq: CLYM), a clinical-stage biotechnology company developing therapeutics for immune-mediated diseases, today announced that it has strengthened its leadership team with the addition of Susan Altschuller, Ph.D., MBA,
Regenx Announces Issuance of Cease Trade Order GlobeNewswire October 01, 2025 EDMONTON, Alberta, Oct. 01, 2025 (GLOBE NEWSWIRE) — Regenx Tech Corp., (the “Corporation” or “Regenx“) (CSE: RGX) (OTCQB: RGXT) (FSE: YRS WKN: A2DSW3) announces that, further to its news releases dated July 24, 2025 and September 16, 2025, the management cease trade order granted
C4 Therapeutics Announces Clinical Trial Collaboration and Supply Agreement with Pfizer for the Combination of Cemsidomide and Elranatamab for the Treatment of Relapsed/Refractory Multiple Myeloma GlobeNewswire October 01, 2025 WATERTOWN, Mass., Oct. 01, 2025 (GLOBE NEWSWIRE) — C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a clinical-stage biopharmaceutical company dedicated to advancing targeted protein degradation science, today
Finprime.pro Secures DASP License from El Salvador's CNAD, Strengthening Commitment to Compliance and Security in Digital Assets GlobeNewswire October 01, 2025 San Salvador, El Salvador, Oct. 01, 2025 (GLOBE NEWSWIRE) — Finprime.pro, a brand of Digital Trading Group of Central America S.A. DE C.V., a next-generation crypto broker dedicated to providing secure and transparent access
Black Diamond Group Limited Announces Timing for Third Quarter 2025 Financial Results and Conference Call GlobeNewswire October 01, 2025 CALGARY, Alberta, Oct. 01, 2025 (GLOBE NEWSWIRE) — Black Diamond Group Limited (“Black Diamond” or the “Company”) (TSX: BDI, OTCQX:BDIMF), a leading provider of space rental and workforce accommodation solutions, today announces the timing of its
Close-Up International Selected by VS Health Group to Deliver Market Access Business Intelligence CRM Solution GlobeNewswire October 01, 2025 PRINCETON, N.J., Oct. 01, 2025 (GLOBE NEWSWIRE) — Close-Up Intl, a global leader in AI-powered CRM market data and business intelligence solutions for the pharmaceutical industry, announced it has been selected by VS Health Group (Viking
Baker Hughes to Supply Liquefaction Train Equipment for Sempra Infrastructure's Port Arthur LNG Phase 2 Project GlobeNewswire October 01, 2025 Contract awarded by Bechtel to supply primary liquefaction equipment for two trains, including four Frame 7 gas turbines and eight centrifugal compressors Baker Hughes will also provide two motor-driven compressors for the plant's booster services
High Bar Brands expands Panelite portfolio with launch of Elite and Select subbrands Company promises further support of the heavy-duty aftermarket GlobeNewswire October 01, 2025 OWATONNA, Minn., Oct. 01, 2025 (GLOBE NEWSWIRE) — High Bar Brands (HBB), parent company of Panelite, today announced the launch of two new stainless steel subbrands – Elite and Select